Tag

Agharkar Research Institute

2 articles

ARI Pune Develops MUC1-Targeted Breast Cancer Nanomedicine

Agharkar Research Institute scientists developed a biodegradable nanocarrier for targeted gene therapy in breast cancer. The platform uses MUC1-specific aptamers to deliver siRNA against two anti-apop

Agharkar Research Institute Develops Breast Cancer Nanomedicine Platform

Agharkar Research Institute scientists developed a biodegradable nanocarrier platform for targeted breast cancer gene therapy. The system enables dual-gene silencing of MCL-1 and Survivin genes, resul